Bausch Health
BHC
$8.96
Share price
-7.04%
Change (1 day)
-42.77%
Change (1 year)
Categories
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.
Revenue for Bausch Health (BHC)
Revenue in 2024 (TTM): A$14.63 Billion
According to Bausch Health
's latest financial reports the company's current revenue (TTM 
) is A$15.18 Billion. .The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Bausch Health from 1996 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | A$15.47 B | |
| 2022 | A$11.93 B | 2.62% |
| 2021 | A$11.63 B | 11.44% |
| 2020 | A$10.43 B | -15.02% |
| 2019 | A$12.28 B | 3.27% |
| 2018 | A$11.89 B | 6.45% |
| 2017 | A$11.17 B | -16.73% |
| 2016 | A$13.42 B | -6.23% |
| 2015 | A$14.31 B | 41.74% |
| 2014 | A$10.09 B | 56.1% |
| 2013 | A$6.46 B | 89.53% |
| 2012 | A$3.41 B | 42.05% |
| 2011 | A$2.40 B | 106.6% |
| 2010 | A$1.16 B | 27.33% |
| 2009 | A$0.91 B | -14.9% |
| 2008 | A$1.07 B | 11.33% |
| 2007 | A$0.96 B | -28.43% |
| 2006 | A$1.34 B | 5.21% |
| 2005 | A$1.28 B | 12.02% |
| 2004 | A$1.14 B | 3.13% |
| 2003 | A$1.10 B | -20.77% |
| 2002 | A$1.39 B | 22.38% |
| 2001 | A$1.14 B | 103.57% |
| 2000 | A$0.56 B | 111.87% |
| 1999 | A$0.26 B | 43.71% |
| 1998 | A$0.18 B | 45.79% |
| 1997 | A$0.12 B | 51.74% |
| 1996 | A$83.35 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | A$0.35 M | -100.00% | 🇺🇸 USA |
 | A$1.12 B | -92.59% | 🇺🇸 USA |